title: Is sclerotherapy useful for cherry angiomas?
abstract: BACKGROUND
  Sclerotherapy is a safe, effective, and easily available treatment modality, its role in cherry hemangioma is still unexplored.
  
  
  OBJECTIVE
  This study aims at establishing the role and efficacy of sclerotherapy in treating cherry angiomas and its dermatological complications.
  
  
  METHODS
  This prospective study included 20 patients with 100 lesions of cherry hemangiomas of size >0.2 mm. Intralesional injection of 0.1 mL of 3% sodium tetradecyl sulfate was used. Scarring, if any, was evaluated using "The Stony Brook Scar Evaluation Scale." Patients were called for weekly sessions for a maximum of 4 weeks.
  
  
  RESULTS
  Of 100 lesions treated, 42 lesions responded with a single dose of sclerosant, 44 lesions required a second setting. Remaining lesions were injected for 3 weeks, of which 14 lesions did not remit completely and required a fourth sitting. Depending on response to sclerotherapy, patients were divided into 2 groups (Group A and Group B). On comparing these groups, no statistically significant (χ test) difference in the rate of healing was observed.
  
  
  CONCLUSIONS
  Sclerotherapy with sodium tetradecyl sulfate 3% is effective in the treatment of cherry hemangiomas. It offers an economical alternative to other available conventional methods.
authors.affiliation: Departments of *Dermatology, Venereology, and Leprosy; †Orthopedics, Pt. B.D. Sharma Post Graduate Institute of Medical Sciences, Rohtak, India.
authors.forename: Vijayeeta
authors.initials: V
authors.lastname: Jairath
authors.forename: Surbhi
authors.initials: S
authors.lastname: Dayal
authors.forename: Vijay Kumar
authors.initials: VK
authors.lastname: Jain
authors.forename: Nidhi
authors.initials: N
authors.lastname: Jindal
authors.forename: Paritosh
authors.initials: P
authors.lastname: Gogna
authors.forename: Manu
authors.initials: M
authors.lastname: Sehrawat
authors.forename: Sarabjit
authors.initials: S
authors.lastname: Kaur
authors.forename: Poonam
authors.initials: P
authors.lastname: Verma
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002921:Cicatrix / Q000209:etiology; D005260:Female; D006391:Hemangioma / Q000628:therapy*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D019233:Retreatment; D012597:Sclerosing Solutions / Q000008:administration & dosage*; D015911:Sclerotherapy / Q000009:adverse effects; D012878:Skin Neoplasms / Q000628:therapy*; D012981:Sodium Tetradecyl Sulfate / Q000008:administration & dosage*; D055815:Young Adult
chemical_list: D012597:Sclerosing Solutions; D012981:Sodium Tetradecyl Sulfate